Company attributes
Industry
B2X
CEO
AngelList URL
Parent Organization
Legal classification
Date Incorporated
2013
Number of Employees (Ranges)
501 – 1,000
Phone Number
+18003322056
Full Address
400 Dexter Ave N Ste 1200 Seattle, WA, 98109-5094 United States
CIK Number
Place of Incorporation
IRS Number
463,656,2750
Founded Date
January 1, 2013
Total Funding Amount (USD)
382,091,552
Latest Funding Round Date
October 2017
Latest Funding Type
Patents Assigned (Count)
10
Wellfound ID
Country
Headquarters
Other attributes
Acquirer
Company Operating Status
Active
SIC Code
2,8360
Wikidata ID
Juno Therapeutics is a biopharmaceutical company focused on the development of clinical stage medicines for the treatment of serious diseases. The company was founded by Isabelle Rivière, Michael Jensen and Michel Sadelain in 2013 in Seattle, Washington, and was acquired by Celgene in January 2018.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
